| |
 |
 |
 |
|
"These products are not offered in countries where valid patents exist.
However,final responsibility with respect to third party's patent rights
in a specific country lies exclusively with the user."
ACTIVE
PHARMACEUTICAL INGREDIENTS
- Ciprofloxacin Hydrochloride UPS
(U.S.DMF No. 17786)
- Diclofenac Acid
(U.S.DMF No. 15366)
- Diclofenac Diethylamine BP
(Spain DMF No. DD-708 / 01)
- Diclofenac Potassium BP/EP
(Plant approved by FDA, U.S.A. - U.S.DMF No. 15074)
- Diclofenac Sodium BP/EP/USP
(U.S. DMF No 12469)
(Certicate of Suitability No. R1-CEP-1997-041-REV 00) dtd. 18th
March, 2003.
- Diclofenac Sodium BP/EP/USP also Injectable Grade
- Metronidazale BP/EP/USP
(Plant approved by FDA, U.S.A. - U.S.DMF No. 3675)
(Plant approved by T.G.A. Australia)
(Certicate of Suitability No. R1-CEP 1997-083- REV 00) dtd. 20th
July, 2003.
(Canadian DMF No.2001 - 054)
- Metronidazole BP/EP/USP also Injectable Grade
- Metronidazole Benzoate BP/EP/USP
(Benzoyl Metronidazole)
- Nifedipine BP/EP/USP
(US DMF No. 16730)
(Certificate of Suitability No. RO-CEP 2000-096- REV. 01) dtd.
29th June, 2003.
|
| |
INTERMEDIATES
- 2-Methylimidazole
- N- Chloroacetyl N- Phenyl2,6 Dichloro Aniline (CPDCA)
- 1- (2,6- Dichlorophenyl)- 2- Indolinone (INDOLINONE)
|
|
| Brands |
API
| Formulations |
 |
| |
|